Trial Profile

Single and Double Dose of 2009 Pandemic Influenza A H1N1 Vaccine are equally immunogenic in HIV-infected adolescents and young adults

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 01 Oct 2011

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Influenza A virus vaccine-H1N1 (Primary) ; Influenza virus vaccine; MF 59
Indications Influenza A virus H1N1 subtype; Influenza A virus H3N2 subtype; Influenza virus infections
Focus Adverse reactions; Pharmacodynamics

Most Recent Events

01 Sep 2011 Results published in Clinical and Vaccine Immunology.
15 Mar 2011 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com